不同术前胆道引流方式对恶性梗阻性黄疸胆汁细菌培养及耐药性的影响

Effects of different preoperative biliary drainage methods on bile bacterial culture and drug resistence of malignant obstructive jaundice

  • 摘要:
    目的 探讨不同术前胆道引流方式对恶性梗阻性黄疸胆汁细菌培养及耐药性的影响。
    方法 采用回顾性描述性研究方法。收集2015年1月至2018年12月解放军总医院第一医学中心收治的317例恶性梗阻性黄疸病人的临床资料;男216例,女101例;年龄为(62±10)岁。317例病人中,158例术前无胆道引流,115例术前胆道引流方式为经皮经肝穿刺胆道引流(PTCD),44例术前胆道引流方式为经内镜逆行胆道引流(ERBD)。观察指标:(1)不同术前胆道引流方式胆汁细菌培养情况。(2)胆汁细菌培养阳性病人临床病理特征。(3)不同术前胆道引流方式胆汁细菌耐药性情况。正态分布的计量资料以x±s表示,计数资料以绝对数或百分比表示,组间比较采用χ²检验,两两比较进行Bonferroni校正,多重比较中检验水准为0.016 7。
    结果 (1)不同术前胆道引流方式胆汁细菌培养情况:317例病人中,116例细菌培养阳性,包括43个菌种共168株菌株,其中术前无胆道引流36例(46株),行PTCD 39例(49株),行ERBD 41例(73株)。①317例病人细菌培养阳性率为36.59%(116/317),术前无胆道引流、行PTCD、行ERBD病人细菌培养阳性率分别为22.78%(36/158)、33.91%(39/115)、93.18%(41/44),3者细菌培养阳性率比较,差异有统计学意义(χ²=74.066,P<0.05),其中术前行PTCD与术前无胆道引流病人比较,差异无统计学意义(χ²=4.137,P>0.016 7),术前行ERBD与术前无胆道引流和行PTCD病人比较,差异均有统计学意义(χ²=72.305,44.718,P<0.016 7)。②多重细菌感染占比为36.21%(42/116),术前无胆道引流、行PTCD、行ERBD病人多重细菌感染占比分别为19.44%(7/36)、23.08%(9/39)、63.41%(26/41),3者多重细菌感染占比比较,差异有统计学意义(χ²=20.431,P<0.05),其中术前行PTCD与术前无胆道引流病人比较,差异无统计学意义(χ²=0.147,P>0.016 7),术前行ERBD与术前无胆道引流和行PTCD病人比较,差异均有统计学意义(χ²=15.133,13.215,P<0.016 7)。③多重耐药菌占比为30.95%(52/168),术前无胆道引流、行PTCD、行ERBD病人多重耐药菌占比分别为15.22%(7/46)、26.53%(13/49)、43.84%(32/73),3者多重耐药菌占比比较,差异有统计学意义(χ²=11.447,P<0.05),其中术前行PTCD与术前无胆道引流病人比较,差异无统计学意义(χ²=1.827,P>0.016 7),术前行ERBD与术前无胆道引流病人比较,差异有统计学意义(χ²=10.490,P<0.016 7),术前行ERBD与术前行PTCD病人比较,差异无统计学意义χ²=3.772,P>0.016 7)。(2)胆汁细菌培养阳性病人临床病理特征:病人年龄、腹部手术史、黄疸程度、胆道梗阻位置均与细菌培养阳性无关(χ²=4.865,1.423,4.922,0.030,P>0.05)。(3)不同术前胆道引流方式胆汁细菌耐药性情况:术前无胆道引流病人中革兰氏阳性菌对呋喃妥因、利奈唑烷、替加环素耐药率均为0,革兰氏阴性菌对哌拉西林他唑巴坦、庆大霉素、妥布霉素、阿米卡星、亚胺培南耐药率均为0。行PTCD病人中革兰氏阳性菌对利奈唑烷、替加环素耐药率均为0。行ERBD病人中革兰氏阳性菌对利奈唑烷、替加环素耐药率均为0。革兰氏阳性菌耐药率最低的前4种抗菌药物分别为利奈唑烷、替加环素、万古霉素和呋喃妥因。革兰氏阴性菌耐药率最低的前4种抗菌药物分别为亚胺培南、哌拉西林他唑巴坦、阿米卡星和妥布霉素。7株真菌菌株对抗真菌药物耐药率为0。
    结论 术前行ERBD的病人更易发生感染性并发症,且耐药菌及多重耐药菌比例高。革兰氏阳性菌感染可选用利奈唑胺、替加环素、万古霉素。革兰氏阴性菌感染可选用亚胺培南、哌拉西林他唑巴坦、阿米卡星、妥布霉素。

     

    Abstract:
    Objective To investigate the effects of different preoperative biliary drainage methods on bile bacterial culture and drug resistence of malignant obstructive jaundice.
    Methods The retrospective and descriptive study was conducted. The clinical data of 317 patients with malignant obstructive jaundice who were admitted to the First Medical Center of Chinese PLA General Hospital from January 2015 to December 2018 were collected. There were 216 males and 101 females, aged (62±10)years. Of 317 patients, 158 cases had no preoperative biliary drainage, 115 received preoperative biliary drainage by percutaneous transhepatic choledochal drainage (PTCD), 44 received preoperative biliary drainage by endoscopic retrograde biliary drainage (ERBD). Observation indicators: (1) bile bacteria in different preoperative biliary drainage methods; (2) clinicopathological characteristics of patients with positive bile bacteria; (3) drug resistance of bile bacteria in different methods of preoperative biliary drainage. Measurement data with normal distribution were expressed as Mean±SD. Count data were expressed as absolute numbers or percen-tages, and comparison between groups was analyzed by the chi-square test. Bonferroni correction was used for pairwise comparison. The inspection level was 0.016 7 in the multiple comparison.
    Results (1) Bile bacteria in different preoperative biliary drainage methods: of 317 patients, 116 cases were positive for bacterial culture, including 168 strains of 43 bacterial types. There were 46 strains from 36 patients without preoperative biliary drainage, 49 strains from 39 patients with preoperative PTCD and 73 strains from 41 patients with preoperative ERBD. ① The positive rate of bacteria for 317 patients was 36.59%(116/317). The positive rates of bacteria for patients without preoperative biliary drainage, patients with preoperative PTCD and patients with preoperative ERBD were 22.78%(36/158), 33.91%(39/115) and 93.18%(41/44). There was a significant difference in the positive rate of bacteria among the three groups (χ2=74.066, P<0.05). There was no significant difference between patients with preoperative PTCD and patients without preoperative biliary drainage (χ2=4.137, P>0.016 7), but there were significant differences between patients with pre-operative ERBD and patients without preoperative biliary drainage or patients with preoperative PTCD (χ2=72.305, 44.718, P<0.016 7). ② The overall multiple bacterial rate was 36.21%(42/116). The multiple bacterial rates for patients without preoperative biliary drainage, patients with preoperative PTCD and patients with preoperative ERBD were 19.44%(7/36), 23.08%(9/39) and 63.41%(26/41). There was a significant difference in multiple bacterial rate among the three groups (χ2=20.431, P<0.05). There was no significant difference between patients with PTCD and patients without preoperative biliary drainage (χ2=0.147, P>0.016 7), but there were significant differences between patients with preoperative ERBD and patients without preoperative biliary drainage or patients with preoperative PTCD (χ2=15.133, 13.215, P<0.016 7). ③ The overall prevalence rate of multi-drug resistant organism was 30.95%(52/168). The prevalence rates of multi-drug resistant organism for patients without preoperative biliary drainage, patients with preoperative PTCD and patients with preoperative ERBD group were 15.22%(7/46), 26.53%(13/49) and 43.84%(32/73). There was a significant difference in the prevalence rate of multi-drug resistant organism among the three groups (χ2=11.447, P<0.05). There was no significant difference between patients with PTCD and patients without preoperative biliary drainage (χ2=1.827, P>0.016 7). There was a significant difference between patients with preoperative ERBD and patients without preoperative biliary drainage (χ2=10.497, P<0.016 7), but there was no significant difference between patients with preoperative ERBD and patients with preoperative PTCD (χ2=3.772, P>0.016 7). (2) Clinicopatho-logical characteristics of patients with positive bile bacteria: age, the history of abdominal surgery, degree of jaundice and location of biliary obstruction of patients were not related to the positive rate of bacterial culture (χ2=4.865, 1.423, 4.922, 0.030, P>0.05). (3) Drug resistance of bile bacteria in different methods of preoperative biliary drainage: for patients without preoperative biliary drainage, the drug resistance rate of Gram-positive bacteria to nitrofurantoin, linezolid and tigecycline was 0, and the drug resistance rate of Gram-negative bacteria to piperacillin/tazobactam, gentamicin, tobramycin, amikacin and imipenem was 0. For patients with PTCD, the drug resistance rate of Gram-positive bacteria to linezolid and tigecycline was 0. For patients with ERBD, the drug resistance rate of Gram-positive bacteria to linezolid and tigecycline was 0. In terms of Gram-positive bacteria, linezolid, tigecycline, vancomycin and nitrofurantoin were the top four antibiotics with the lowest resistance rate. In terms of Gram-negative bacteria, imipenem, piperacillin/tazobactam, amikacin and tobramycinn were the top four antibiotics with the lowest resistance rate. Seven strains of fungi showed no resistance to antifungal drugs.
    Conclusions Patients with preoperative ERBD are more vulnerable to infectious complications, and more likely to form drug resistant organism and multi-drug resistant organism. For Gram-positive bacteria infection, linezolid, tigecycline and vancomycin can be used for treatment. For Gram-negative bacteria infection, imipenem, piperacillin/trzobactam, amikacin and tobramycin can be used for treatment.

     

/

返回文章
返回